← Back to all trials
Recruiting
NCT07069413
Sibwatch: Optimizing Intervention Options for Infants and Toddler Siblings of Autistic Children
Conditions: Autism Sibling
Sex: All
Ages: 6 Months – 24 Months
Healthy volunteers: No
Phase: NA
Enrollment: 140
Sponsor: University of Texas at Austin
Location: VUMC Nashville Tennessee
Summary
This rigorous randomized controlled trial will evaluate the efficacy and acceptability of a preemptive, telehealth intervention (tele-ImPACT) in a large, representative sample of infant siblings of autistic children, who are known to be at high likelihood of receiving a future diagnosis of autism and/or developmental language disorder (HL-Sibs). If our hypotheses are supported, this innovative and interdisciplinary study will provide empirical support for a novel approach to treatment that is theoretically motivated and developmentally informed, as well as accessible for and acceptable to families, and will lend new insights into the developmental windows in which, mechanisms by which, and subgroups for which the treatment works. Such findings would have strong implications for research, policy, theory, and practice in young children at risk for autism and/or language disorder.
Eligibility Criteria
Inclusion Criteria:
* chronological age between 6-24 months
* has at least one older biological sibling diagnosed with autism
Exclusion Criteria:
* adverse neurological history
* primary sensory deficit (hearing or visual impairment)
* pre-term birth (gestation \
Source: ClinicalTrials.gov (NCT07069413). StuddyBuddy aggregates publicly available trial information.